Name: Retatrutide (RT) – Triple Hormone Receptor Agonist – 10mg
Brand: CertPeptides
SKU: CP-RT-10MG
Price: 99.99 USD
Availability: InStock

Product Description

Retatrutide (also known as LY3437943) is a first-in-class triple hormone receptor agonist that activates GIP, GLP-1, and glucagon receptors simultaneously. This novel mechanism makes it one of the most discussed research compounds in the metabolic peptide space, offering a unique pharmacological profile distinct from dual agonists.

Specifications

Purity	≥98% (HPLC)
Physical Form	Lyophilized powder
Storage	-20°C, keep away from light and moisture

Research Applications

Triple incretin receptor signaling analysis
Energy expenditure and metabolic rate studies
Comparative efficacy vs. dual agonist peptides
Glucagon receptor-mediated lipid metabolism research

Disclaimer: This product is intended for laboratory and research use only. Not for human or animal consumption. All handling should be conducted by qualified researchers in accordance with applicable regulations.

Certificate of Analysis

Every batch of Retatrutide sold by CertPeptides is independently tested by a third-party laboratory. The Certificate of Analysis (COA) confirms identity, purity (≥98% via HPLC), and the absence of heavy metals and microbial contamination.

A COA is included with every order. You may also request a batch-specific COA through our contact page.

Laboratory Product Information

📦 Includes

One (1) vial of Retatrutide lyophilized powder (10mg per vial), Certificate of Analysis (COA).

🔬 Purpose

Retatrutide (LY3437943) is a 39-amino-acid triple incretin receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. It is utilized in in-vitro receptor binding and activation assays to characterize tri-agonist pharmacology, cAMP signaling, and incretin pathway cross-talk.

🧬 Ingredients

Retatrutide (LY3437943) triple GIP/GLP-1/glucagon receptor agonist lyophilized powder, ≥98% purity (HPLC verified). No fillers, binders, or excipients.

🔬 Laboratory Handling Information

Molecular Formula: C₂₀₅H₃₂₀N₅₆O₆₃S (approximate; includes fatty acid modification)
Molecular Weight: ~4471 Da
Amino Acid Sequence: 39-amino-acid GIP-based peptide with substitutions conferring GLP-1R/GCGR co-agonism, plus C20 fatty diacid conjugation via lysine for extended receptor occupancy
Solubility: Soluble in sterile aqueous buffers (e.g., bacteriostatic water, PBS) at concentrations suitable for in-vitro applications
Storage: Store lyophilized product at 2–8°C; reconstituted aliquots at −20°C; avoid repeated freeze-thaw cycles
Literature Reference: Referenced at 1–100 nM for in-vitro GIPR/GLP-1R/GCGR binding and cAMP dose–response assays (PubMed: Jastreboff et al., N Engl J Med, 2023)

🚨 IMPORTANT — RESEARCH USE ONLY

FOR RESEARCH USE ONLY – NOT FOR HUMAN OR VETERINARY CONSUMPTION. Not intended for any in vivo use, therapeutic, or diagnostic purpose. No dosing or administration information provided or implied.

🚚 Shipping

Ships in temperature-controlled packaging via priority courier. Most orders ship within 24 hours on business days. Free shipping on orders over $150. Tracking number provided via email upon shipment.

Retatrutide (RT) – Triple Hormone Receptor Agonist – 10mg